INCREASE OF NIGH DENSITY LIPOPROTEINS (HDL) IN POSTMENOPAUSAL WOMEN WITH ESTROGEN REPLACEMENT (ER) THERAPY IS DETERMINED BY GENETIC-POLYMORPHISM OF SERUM HDL-ARYLESTERASE
Jm. Chemnitius et al., INCREASE OF NIGH DENSITY LIPOPROTEINS (HDL) IN POSTMENOPAUSAL WOMEN WITH ESTROGEN REPLACEMENT (ER) THERAPY IS DETERMINED BY GENETIC-POLYMORPHISM OF SERUM HDL-ARYLESTERASE, Journal of the American College of Cardiology, 29(2), 1997, pp. 8134-8134